a. Pfizer revenue for the twelve months ending September 30, 2021 was $69.337B, a 114.44% increase year-over-year.
b. Pfizer annual revenue for 2020 was $41.908B, a 1.79% increase from 2019.
c. Pfizer annual revenue for 2019 was $41.172B, a 0.85% increase from 2018.
d. Pfizer annual revenue for 2018 was $40.825B, a 22.31% decline from 2017.
a. Pfizer gross profit for the twelve months ending September 30, 2021 was $45.185B, a 74.32% increase year-over-year.
b. Pfizer annual gross profit for 2020 was $33.216B, a 0.9% increase from 2019.
c. Pfizer annual gross profit for 2019 was $32.921B, a 3.4% increase from 2018.
d. Pfizer annual gross profit for 2018 was $31.838B, a 22.94% decline from 2017.
a. Pfizer net income for the twelve months ending September 30, 2021 was $19.889B, a 149.36% increase year-over-year.
b. Pfizer annual net income for 2020 was $9.616B, a 40.91% decline from 2019.
c. Pfizer annual net income for 2019 was $16.273B, a 45.91% increase from 2018.
d. Pfizer annual net income for 2018 was $11.153B, a 47.66% decline from 2017